As of 4:02pm ET
| +2.92 / +2.84%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 99.50, with a high estimate of 114.00 and a low estimate of 85.00. The median estimate represents a -6.03% decrease from the last price of 105.89.
The current consensus among 5 polled investment analysts is to Hold stock in Cantel Medical Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.